Alzheimer Disease
Promoter polymorphism in FGF1 gene increases risk of Alzheimer disease
Published in Blood Weekly, October 21st, 2004
"Fibroblast growth factor I (FGF1, also known as acidic FGF) protects selective neuronal populations against neurotoxic effects such as those in Alzheimer's disease (AD) and HIV encephalitis. The FGF1 gene is therefore a strong candidate gene for AD," researchers in Japan report.
"Using the promoter polymorphism of the FGF1 gene," wrote H. Yamagata and coauthors, "we examined the relationship between AD and the FGF1 and apolipoprotein E (APOE) genes in 100 Japanese autopsy-confirmed late-onset AD patients and 106 age-matched non-demented controls."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-10-21)
More Articles from Blood Weekly
- Cord Blood
New cord blood somatic SCs has intrinsic pluripotent differentiation potential - Cord Blood
Umbilical cord blood is a legitimate source of mesenchymal stem cells - HIV/AIDS Coinfection
High frequency of HIV/HBV coinfection in Cote d'Ivoire - Nosocomial Infection
Catheter removal recommended for patients with bloodstream infections - Transfusion Medicine
Many blood donors in southern Taiwan harbor the D/H strains of SEN virus - AIDS/HIV Research
Classic AIDS diagnosed in sooty mangabey after an 18-year natural infection - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
